Literature DB >> 28435766

A Heart too Stiff to Beat: A Case of Familial Transthyretin Amyloidosis Cardiomyopathy.

Yan Zhou1, Sameen Khalid2, Aamer Abbass2, Laura Hughes2, Marcos Hazday3.   

Abstract

Heart failure is a common clinical syndrome caused by a variety of cardiac diseases. We report a rare case of familial transthyretin amyloidosis cardiomyopathy to heighten the awareness of this rare but lethal cause of heart failure, as therapeutic interventions such as liver or heart transplant could be curative in selected patients.

Entities:  

Keywords:  amyloidosis; cardiomyopathy; liver transplant; transthyretin

Year:  2017        PMID： 28435766      PMCID： PMC5398907          DOI： 10.7759/cureus.1106

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  9 in total

Review 1.  The neglected entity of familial cardiac amyloidosis in African Americans.

Authors:  Rodney H Falk
Journal:  Ethn Dis       Date:  2002       Impact factor: 1.847

2.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).

Authors:  Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; Gabriel Gregoratos; Loren F Hiratzka; David P Faxon; Alice K Jacobs; Valentin Fuster; Sidney C Smith
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

Review 3.  Molecular mechanisms of amyloidosis.

Authors:  Giampaolo Merlini; Vittorio Bellotti
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

4.  Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy.

Authors:  L H Connors; G Doros; F Sam; A Badiee; D C Seldin; M Skinner
Journal:  Amyloid       Date:  2011-06       Impact factor: 7.141

5.  Amyloid Cardiomyopathy.

Authors:  Merrill D Benson; Noel R Dasgupta
Journal:  J Am Coll Cardiol       Date:  2016-07-05       Impact factor: 24.094

Review 6.  Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.

Authors:  Morie A Gertz; Merrill D Benson; Peter J Dyck; Martha Grogan; Terresa Coelho; Marcia Cruz; John L Berk; Violaine Plante-Bordeneuve; Hartmut H J Schmidt; Giampaolo Merlini
Journal:  J Am Coll Cardiol       Date:  2015-12-01       Impact factor: 24.094

7.  Implantable cardioverter defibrillators in patients with cardiac amyloidosis.

Authors:  Grace Lin; Angela Dispenzieri; Robert Kyle; Martha Grogan; Peter A Brady
Journal:  J Cardiovasc Electrophysiol       Date:  2013-03-14

8.  Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.

Authors:  Lawreen H Connors; Tatiana Prokaeva; Amareth Lim; Roger Théberge; Rodney H Falk; Gheorghe Doros; Alan Berg; Catherine E Costello; Carl O'Hara; David C Seldin; Martha Skinner
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

9.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.

Authors:  Holger Vogelsberg; Heiko Mahrholdt; Claudia C Deluigi; Ali Yilmaz; Eva M Kispert; Simon Greulich; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  J Am Coll Cardiol       Date:  2008-03-11       Impact factor: 24.094
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.